July 2, 2022 Comments Off on New patent for Ibsa Inst drug LICART Posted in: Patent Added Annual Drug Patent Expirations for LICART Licart is a drug marketed by Ibsa Inst Bio and is included in one NDA. The generic ingredient in LICART is diclofenac epolamine. Additional…
The post New patent for Ibsa Inst drug LICART appeared first on DrugP…
July 2, 2022 Comments Off on New patent for Teva Branded drug PROAIR RESPICLICK Posted in: Patent Added Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Teva Branded drug PROAIR RESPICLICK appea…